ELIEM THERAPEUTICS INC's ticker is and the CUSIP is 28658R106. A total of 23 filers reported holding ELIEM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,981 | – | 14,279 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,583,170 | $4,432,876 | 3.99% |
| RA Capital Management | 13,150,849 | $36,822,377 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 494,089 | $1,383,449 | 0.43% |
| Atom Investors LP | 78,886 | $220,881 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 810,593 | $2,269,660 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 55,223 | $154,624 | 0.00% |
| Chicago Partners Investment Group LLC | 16,570 | $45,733 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 14,279 | $39,981 | 0.00% |
| TUDOR INVESTMENT CORP ET AL | 29,706 | $83,177 | 0.00% |
| NORTHERN TRUST CORP | 11,182 | $31,310 | 0.00% |